Autres langues Ardelyx, Inc.

Actions

ARDX

US0396971071

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 26/04/2024			Pré-ouverture 13:05:00
6,42 ^USD	+1,74 %		6,53	+1,71 %

17/04	ARDELYX, INC. : Wedbush reste à l'achat	ZM
05/04	ARDELYX, INC. : Leerink Partners favorable sur le dossier	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024	18/04
Ardelyx, Inc. Reports Employment Inducement Grants	28/03
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	25/03
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy	25/03
Ardelyx, Inc. Announces the Appointment of Mike Kelliher as Executive Vice President, Corporate Development and Strategy	25/03
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing	22/03
Ardelyx, Inc. Reports Employment Inducement Grants	12/03
Ardelyx, Inc. Reports Employment Inducement Grants	12/03
Ardelyx, Inc. announced that it has received $50 million in funding	05/03
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS	28/02
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference	27/02
Sector Update: Health Care Stocks Mixed Premarket Friday	23/02
Sector Update: Health Care	23/02
Ardelyx's Q4 Swings to Loss; Revenues Down; Shares Down After-Hours	23/02
Ardelyx: Q4 Earnings Snapshot	22/02
Ardelyx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	22/02
Ardelyx, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	22/02
Earnings Flash (ARDX) ARDELYX Posts Q4 Revenue $34.4M, vs. Street Est of $34.2M	22/02
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	22/02
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024	01/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ardelyx, Inc.

Actions

ARDX

US0396971071

Autres langues

Filtres